2011
Neuroimaging offers a promising tool for the priority goals of current researches in Alzheimer’s disease (AD) including early diagnosis, monitoring (…)
Consulter 
2011
Longer life expectancies lead to increases in the prevalence of age-associated illnesses. The number of Australians with dementia is predicted (…)
Consulter
2011
The ‘preclinical’ phase of Alzheimer’s disease is a future target for treatment, but additional research is essential to understand the (…)
Consulter
2011
To assess the diagnostic potential of imaging striatal monoaminergic terminal integrity with the vesicular monoamine transporter type 2 (VMAT2) radioligand (…)
Consulter
2011
To provide guidance regarding the most appropriate voxel-based morphometry (VBM)-derived method for assessing hippocampal atrophy in early Alzheimer’s disease (AD).
Consulter
2011
In the past decade, a "default mode network" (DMN) has been highlighted in neuroimaging studies as a set of brain (…)
Consulter
